Drug Database
FS

FSH (rFSH, LGLS / LBFS0101 / FSH, LG Chem)

✓ Approved

LG Chem Ltd. · FSHR · 重组蛋白

什么是 FSH?

FSH 是一种重组蛋白,由LG Chem Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection、Subcutaneous Injection。

药物档案

商品名rFSH, LGLS, LBFS0101, FSH, LG Chem
公司LG Chem Ltd.
药物类别重组蛋白
分子靶点FSHR
给药途径Injectable (Others), Intramuscular (IM) Injection, Subcutaneous Injection
状态Approved

作用机制

分子靶点

FSH 作用于 1 个分子靶点:

FSHRfollicle stimulating hormone receptor (FSHRO, ODG1)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

FSH 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Reproductive system and breast disordersInfertility female✓ Approved

相关研究文献

PubMedBMC veterinary research2026-11-19

The interactive regulatory effects of light exposure and bamboo fiber supplementation on growth performance, hormone levels, and gut microbiome composition in white-feathered broiler breeder chickens.

Wang Zhiyao Z, Qiu Huiling H, Qiao Changming C, Song Shujun S et al.

This study investigated the interactive effects of light intensity (4 Lux vs. 5 Lux) and bamboo fiber supplementation (0% vs. 1%) on growth performance, reproductive hormones, antioxidant status, laying performance, egg quality, and intestinal flora in Arbor Acres broiler breeders. A total of 32,000 Arbor Acres white broiler breeder hens at 49 days of age were randomly assigned to four treatment groups: 4 Lux basal diet, 5 Lux basal diet, 4 Lux + 1% bamboo fiber, and 5 Lux + 1% bamboo fiber, with eight replicates per group and 1,000 hens per replicate. The experimental period was 126 days. Two-way ANOVA showed significant light × fiber interactions for estradiol, GSH-Px, MDA, and eggshell lightness L (P < 0.05). Light intensity alone affected FSH, UA, and eggshell color a* (P < 0.05). One-way ANOVA with post-hoc comparisons further showed that the 5 Lux + bamboo fiber group achieved the highest laying rate (45.40%) and significantly increased MT levels (54.61%). Compared to the 4 Lux group, the 5 Lux group showed increased FSH, E2, and GSH-Px activity, but decreased eggshell thickness (P < 0.05). Relative to the 5 Lux group, the 5 Lux + bamboo fiber group exhibited increased GSH, MDA, and GSH-Px, but decreased E2, ALB, and γ-GT (P < 0.05). This group also significantly reshaped the intestinal flora structure, increasing the Firmicutes/Bacteroidetes ratio from 1.91 to 19.34 and enriching beneficial bacteria such as Lactobacillus and Limosilactobacillus. Combined 5 Lux lighting and 1% bamboo fiber improved laying rate and antioxidant status. These results suggest that light intensity and fiber intake can be managed together to support breeder performance.

PMID 43053087
阅读全文 →
PubMedBMC women's health2026-11-19

Clinical efficacy of hysteroscopic Mirena ring broken-arm slipknot suture fixation for adenomyosis.

Feng Guodan G, Chen Guangyuan G, Nie Zhiwei Z, Lan Kangyun K et al.

To evaluate the clinical efficacy and safety of hysteroscopic Mirena ring broken-arm slipknot suture fixation (BA) compared with non-broken-arm slipknot suture fixation (NBA) and Giman ring anchor fixation (Giman) for the treatment of adenomyosis (AM). A total of 102 patients with AM treated from October 2023 to July 2025 were retrospectively enrolled and divided into three groups: BA group (n = 40), NBA group (n = 45), and Giman group (n = 17). Clinical efficacy, pain scores (VAS), menstrual blood loss (PBAC), sex hormone levels (E2, FSH, LH), endometrial thickness, and uterine cavity depth were compared using generalized estimating equations (GEE), repeated measures ANOVA, and difference-in-differences (DID) models. Causal forest analysis was applied to estimate individualized treatment effects. Adverse events were assessed by Log-binomial regression. The overall effective rate was 92.50% in the BA group, 84.44% in the NBA group, and 64.71% in the Giman group (P < 0.05). GEE analysis showed that both the BA and NBA groups had significantly lower PBAC and VAS scores compared with the Giman group across all follow-up time points (P < 0.05). Repeated measures ANOVA revealed significant interaction effects between treatment method and time on sex hormone levels (P < 0.001). DID analysis demonstrated that the BA group had the greatest reduction in endometrial thickness and uterine cavity depth. The total adverse event rate was significantly lower in the BA group than in the other two groups (RR < 1, P < 0.05). In this retrospective cohort, hysteroscopic Mirena ring broken-arm slipknot suture fixation was associated with better 12-month clinical outcomes and fewer adverse events compared with the NBA and Giman approaches for treating AM.

PMID 43052942
阅读全文 →
PubMedMethods in molecular biology (Clifton, N.J.)2026-11-19

Beyond Fertility: Pioneering AI-Enhanced Health Solutions with AMH and Inhibin B.

Xu Huiyu H, Bishop Farideh F, Wang Haijun H, Duin Marcel van MV et al.

The review article underscores the pivotal roles of Anti-Müllerian Hormone (AMH) and Inhibin B in the realm of reproductive health. AMH, with its stable secretion patterns irrespective of the menstrual cycle, serves as a robust indicator of the quantity of remaining oocytes, offering a reliable measure for ovarian reserve, predicting ovarian longevity and fertility potential. This makes AMH an indispensable tool in both fertility assessments for women contemplating delayed childbearing and in evaluating the risk of conditions like premature ovarian insufficiency. On the other hand, Inhibin B provides critical insights into ovarian function. Its levels peak during the early follicular phase and are closely tied to the growth of the dominant follicle, regulated by and in turn regulating Follicle Stimulating Hormone (FSH). This interplay offers a dynamic view of the real-time ovarian response, thus contributing to the chances of successful outcomes. The integration of these biomarkers and other common clinical indicators into AI-driven diagnostic tools marks a significant advancement in personalized medicine. Such tools leverage complex algorithms to analyze biomarker levels and predict individual reproductive outcomes with greater accuracy. The future of these biomarkers in clinical practice looks promising, with ongoing research aimed at refining their predictive power and expanding their application. Innovations in biomarker technology and data analytics are expected to further enhance the precision of reproductive health diagnostics, enabling earlier and more accurate interventions that can lead to better health outcomes for women worldwide. By deepening the understanding of these hormonal interactions and their implications, the field moves closer to a more comprehensive and nuanced approach to managing reproductive health, illustrating the profound impact of integrating endocrine science with cutting-edge technology.

PMID 43052673
阅读全文 →
PubMedJCEM case reports2026-11-18

Functioning gonadotropinomas with ovarian hyperstimulation and multicystic ovaries: a tale of 2 tumors and 2 organs.

Ghosh Jayaditya J, Mahadevan Shriraam S, Shah Ravi R, Sundaram Sandhya S et al.

Functioning gonadotropinomas are rare pituitary adenomas that secrete biologically active gonadotropins and may present with ovarian hyperstimulation and multicystic ovarian enlargement in premenopausal women, often mimicking primary ovarian disease and leading to delayed diagnosis. We describe 2 women with ovarian manifestations secondary to functioning gonadotropinomas. Case 1 was a 36-year-old woman who presented with a 12-year history of abnormal uterine bleeding and bilateral multicystic ovaries initially suspected to be ovarian neoplasms. Later, she developed progressive visual impairment in the right eye. Laboratory tests showed an elevated follicle-stimulating hormone (FSH) level, and pituitary magnetic resonance imaging revealed a macroadenoma. Transsphenoidal surgery confirmed an FSH/luteinizing hormone-positive gonadotroph adenoma, with postoperative regression of ovarian cysts. Case 2 was a 28-year-old woman who presented with severe abdominal pain and bilateral multicystic ovaries complicated by ovarian torsion requiring unilateral ovariectomy and salpingectomy. Persistent ovarian enlargement with elevated gonadotropins and estradiol prompted endocrine evaluation, revealing a pituitary macroadenoma. Histopathology demonstrated FSH and steroidogenic factor 1-positive functioning gonadotropinoma. Following surgery, ovarian cysts regressed, menstrual cycles normalized within 6 months, and spontaneous conception occurred. These cases emphasize the need to consider pituitary pathology in women with unexplained multicystic ovaries and ovarian hyperstimulation syndrome-like features.

PMID 43047272
阅读全文 →
PubMedBiomeditsinskaia khimiia2026-11-18

The effect of the synthetic analogue of kisspeptin on the level of hormones of the reproductive system in Danio rerio.

Kostina M I MI, Blazhenko A A AA, Glebskaya S A SA, Nuzhnova A A AA et al.

One of the modern approaches in pharmacology is to conduct research on the Danio rerio model organism, characterized by high genetic conservativeness. Kisspeptin is one of the neuropeptides responsible for regulating reproductive function, and its synthetic analogues may have improved stability and bioavailability. The aim of the research was to study and analyze the effects of the synthetic analogue of kiss1 (SAK1) of D. rerio, consisting of 14 amino acids, produced in the Department of General Pathology and Pathological Physiology of the Institute of Experimental Medicine on female D. rerio fish after spawning. For the experiments, SAK1 and buserelin-depot were used as a reference compound. The fishes were anesthetized using lidocaine, then pharmacological agents were administered intracerebrally into ventricle region (midbrain-cerebellum region). SAK1 was administered at two doses: 1 ng and 4 ng per fish (equivalent to 0.60 pmol and 2.36 pmol). Gonadectomy was performed following the administration of the substance. SAK1 administration caused an increase in the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and progesterone and a decrease in the testosterone levels, without any effect on the estradiol levels. Administration of buserelin increased concentrations of progesterone, FSH, and LH, and decreased testosterone levels without changes in estradiol levels, compared to the control group. The diverse trends observed in hormone level fluctuations (both within and outside the particular biochemical pathway) demonstrate that the peptide exerts both inhibitory and stimulatory effects. This may have significant implications for future research into the regulation of the relevant biological processes.

PMID 43046915
阅读全文 →
PubMedFrontiers in reproductive health2026-11-18

Follitropin alfa versus follitropin alfa/lutropin alfa (rFSH/rLH) in progestin-primed ovarian stimulation: a prospective two-center observational cohort study.

Pabuccu Emre E, Tohma Yusuf Aytac YA, Ozkavukcu Sinan S

The contribution of recombinant LH during progestin-primed ovarian stimulation (PPOS) remains uncertain. We compared recombinant FSH alone (GON) with recombinant FSH plus recombinant LH (PER) in a prospective two-center observational cohort. The full enrolled cohort included 213 women (121 GON; 92 PER), including 11 with day-3 transfer. MII oocyte count was the primary outcome. The primary negative binomial model adjusted for female age, AMH, baseline AFC, previous failed cycles and center. Propensity scores used the same covariates; matching was 1:1, exact within center, using Mahalanobis distance within a logit propensity-score caliper. The per-protocol (PP) population comprised the 202 women whose embryos were cultured to day 5; in the full-cohort (ITT) analysis, the 11 women with day-3 transfer contributed zero day-5 blastocysts. The primary adjusted MII incidence rate ratio (IRR) for PER versus GON was 1.01 (95% CI 0.91-1.11; p = 0.910); the PP IRR was 1.00 (95% CI 0.91-1.11; p = 0.939). The number of MII oocytes was similar in both groups (median 11 in both), and this finding did not change after adjustment for baseline characteristics or after propensity-score matching. PER was associated with more day-5 blastocysts (median 4 vs. 3) and more top-quality blastocysts (median 2 vs. 1), and these differences persisted after adjustment and matching. Positive β-hCG rates after the first frozen embryo transfer were similar (47.6% vs. 43.2%). OHSS was rare (1 PER and 2 GON cases, all mild), and no cycle was canceled. No statistically significant difference in MII count was detected, and equivalence was not established. The higher day-5 blastocyst counts associated with PER may reflect an effect of LH on embryo developmental competence rather than on oocyte yield; this exploratory finding does not establish a causal or clinical benefit and requires confirmation in randomized trials. https://clinicaltrials.gov/study/NCT07348757, NCT07348757.

PMID 43047481
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多FSH